Form 4 for VYGR Voyager Therapeutics, Inc.
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001104659-23-078152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-06-30 | VYGR | Carter Todd Alfred | CSO | M - OptEx | $2.85 | +5,000 | 70.4K | +8% | +$14.2K |
| D | 2023-07-05 | 2023-06-30 | VYGR | Carter Todd Alfred | CSO | S - Sale+OE | $11.41 | -5,000 | 65.4K | -7% | -$57.0K |
| D | 2023-07-05 | 2023-06-30 | VYGR | Carter Todd Alfred | CSO | M - OptEx | $0.00 | -5,000 | 45.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | M | A | 5,000 | $2.85 | 70,360 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-30 | S | D | 5,000 | $11.41 | 65,360 | D | — | — | (F1) The reported sale of 5,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-30 | M | D | 5,000 | $0.00 | 45,000 | D | $2.85 · — to 2032-01-13 | 5,000 Common Stock | (F2) This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The vesting commencement date of the option is the grant date, January 13, 2022. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service. |